Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassem Sadek

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Frontiers in Neuroscience|February 28, 2018
The Histamine H3 Receptor Antagonist DL77 Ameliorates MK801-Induced Memory Deficits in RatsNermin Eissa, Nadia Khan, Shreesh K Ojha, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of AutismNermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|December 15, 2015
Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and DevelopmentCharu Sharma, Bassem Sadek, Sameer N Goyal, et al.
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Apigenin Alleviates Autistic-like Stereotyped Repetitive Behaviors and Mitigates Brain Oxidative Stress in MicePetrilla Jayaprakash, Dmytro Isaev, Keun-Hang Susan Yang, et al.
Behavioural Brain Research|October 16, 2015
The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in ratsNadia Khan, Ali Saad, Syed M Nurulain, et al.
Frontiers in Immunology|December 22, 2025
The role of interleukin-37 and interleukin-38 in the development and remission of autism spectrum disorder: a comprehensive review of neuroinflammatory mechanisms and potential therapeutic implicationsZakeya Al Rasbi, Hiba Orsud, Sumaya Hasan Zoughbor, et al.
Drug Design, Development and Therapy|February 7, 2018
Anticonvulsant and reproductive toxicological studies of the imidazole-based histamine H3R antagonist <b>2-18</b> in miceSalim M Bastaki, Yousef M Abdulrazzaq, Mohamed Shafiullah, et al.
European Journal of Medicinal Chemistry|March 22, 2014
Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moietiesBassem Sadek, Johannes Stephan Schwed, Dhanasekaran Subramanian, et al.
Current Pharmaceutical Design|March 23, 2016
Phytochemicals as Prototypes for Pharmaceutical Leads Towards Drug Development Against Diabetic CardiomyopathyShreesh Ojha, Amani Kurdi, Bassem Sadek, et al.
Frontiers in Pharmacology|April 4, 2019
Plant Extracts and Phytochemicals Targeting <i>α</i>-Synuclein Aggregation in Parkinson's Disease ModelsHayate Javed, Mohamed Fizur Nagoor Meeran, Sheikh Azimullah, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Frontiers in Neuroscience|February 28, 2018
The Histamine H3 Receptor Antagonist DL77 Ameliorates MK801-Induced Memory Deficits in RatsNermin Eissa, Nadia Khan, Shreesh K Ojha, et al.
Pharmaceuticals (Basel, Switzerland)|August 26, 2022
Experimental Studies Indicate That ST-2223, the Antagonist of Histamine H3 and Dopamine D2/D3 Receptors, Restores Social Deficits and Neurotransmission Dysregulation in Mouse Model of AutismNermin Eissa, Karthikkumar Venkatachalam, Petrilla Jayaprakash, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|December 15, 2015
Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and DevelopmentCharu Sharma, Bassem Sadek, Sameer N Goyal, et al.
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
Apigenin Alleviates Autistic-like Stereotyped Repetitive Behaviors and Mitigates Brain Oxidative Stress in MicePetrilla Jayaprakash, Dmytro Isaev, Keun-Hang Susan Yang, et al.
Behavioural Brain Research|October 16, 2015
The dual-acting H3 receptor antagonist and AChE inhibitor UW-MD-71 dose-dependently enhances memory retrieval and reverses dizocilpine-induced memory impairment in ratsNadia Khan, Ali Saad, Syed M Nurulain, et al.
Frontiers in Immunology|December 22, 2025
The role of interleukin-37 and interleukin-38 in the development and remission of autism spectrum disorder: a comprehensive review of neuroinflammatory mechanisms and potential therapeutic implicationsZakeya Al Rasbi, Hiba Orsud, Sumaya Hasan Zoughbor, et al.
Drug Design, Development and Therapy|February 7, 2018
Anticonvulsant and reproductive toxicological studies of the imidazole-based histamine H3R antagonist <b>2-18</b> in miceSalim M Bastaki, Yousef M Abdulrazzaq, Mohamed Shafiullah, et al.
European Journal of Medicinal Chemistry|March 22, 2014
Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moietiesBassem Sadek, Johannes Stephan Schwed, Dhanasekaran Subramanian, et al.
Current Pharmaceutical Design|March 23, 2016
Phytochemicals as Prototypes for Pharmaceutical Leads Towards Drug Development Against Diabetic CardiomyopathyShreesh Ojha, Amani Kurdi, Bassem Sadek, et al.
Frontiers in Pharmacology|April 4, 2019
Plant Extracts and Phytochemicals Targeting <i>α</i>-Synuclein Aggregation in Parkinson's Disease ModelsHayate Javed, Mohamed Fizur Nagoor Meeran, Sheikh Azimullah, et al.
Pageof 10